The Safe Guide to Debridement in the Challenging Clinical Setting

Dr Aliza Lee

Wound Masterclass, Volume 1: Issue 3 – Dec 2022 p22-26

Debridement should be carried out as part of standard care treatment. Safety and minimizing of complications are essential when carrying out debridement in various clinical settings. Standard of care for debridement involves initial debridement to healthy tissue and any further weekly debridements as required. Debridement methods can be generalized into five broad categories, autolytic, enzymatic, biologic, mechanical and sharp debridement. This article explores how wound debridement in anticoagulated patients can be achieved safely with use of a chitosan-based hemostatic agent.

Conclusions

Results of the case series presented here support the use of the chitosan-based hemostatic agent following guideline recommended sharp debridement to bleeding tissue in patients on anticoagulant therapy given its ability to achieve rapid hemostasis. In addition to the ability to achieve rapid hemostasis in this patient population, use of the chitosan-based hemostatic agent may help expedite wound resolution due to its ability to promote early advanced wound care product use and the potentially beneficial inherent properties of chitosan.

You can read the full article here on page 22.